“INFECTIOUS RISKS AND COMPLICATIONS IN ADULT LEUKEMIC PATIENTS RECEIVING BLINATUMOMAB”, Mediterr J Hematol Infect Dis, vol. 10, no. 1, p. e2018029, May 2018, doi: 10.4084/mjhid.2018.029.